Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder thought to be associated with mitochondrial dysfunction. Loss of function mutations in the putative mitochondrial protein PINK1 (PTEN-induced kinase 1) have been linked to familial forms of PD, but the relation of PINK1 to mammalian mitochondrial function remains unclear. Here, we report that germline deletion of the PINK1 gene in mice significantly impairs mitochondrial functions. Quantitative electron microscopic studies of the striatum in PINK1 −/− mice at 3–4 and 24 months revealed no gross changes in the ultrastructure or the total number of mitochondria, although the number of larger mitochondria is selectively increased. Functional assays showed impaired mitochondrial respiration in the striatum but not in the cerebral cortex at 3–4 months of age, suggesting specificity of this defect for dopaminergic circuitry. Aconitase activity associated with the Krebs cycle is also reduced in the striatum of PINK1 −/− mice. Interestingly, mitochondrial respiration activities in the cerebral cortex are decreased in PINK1 −/− mice at 2 years compared with control mice, indicating that aging can exacerbate mitochondrial dysfunction in these mice. Furthermore, mitochondrial respiration defects can be induced in the cerebral cortex of PINK1 −/− mice by cellular stress, such as exposure to H 2 O 2 or mild heat shock. Together, our findings demonstrate that mammalian PINK1 is important for mitochondrial function and provides critical protection against both intrinsic and environmental stress, suggesting a pathogenic mechanism by which loss of PINK1 may lead to nigrostriatal degeneration in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, when PINK1 is mutated, it loses its function, which means there is no longer any protection against ROS [141].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [141]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Gautier et al, 2008
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“The recent discovery of recessively inherited loss of function mutations in three distinct genes that are linked to early onset parkinsonism (7–9) has provided a unique opportunity to create in vivo models to identify early pathogenic changes, which may ultimately lead to neurodegeneration (10).”
Self-citationChronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683 · cited 1×
“Accidental exposure to mitochondrial toxins leads to symptoms resembling those of PD via the selective death of dopaminergic neuron (5, 6).”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 1×
“Bioinformatics analysis reveals that PINK1 is a putative serine-threonine kinase with a mitochondrial targeting motif at its N-terminal end (9).”
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · cited 1×
“A growing number of clinical and experimental reports implicate mitochondrial dysfunctions and oxidative stress in the pathogenesis of PD (1, 2).”
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 2×
“In fact, two recent articles showed dramatic functional and structural impairments of mitochondria in Drosophila bearing null mutations for dPINK1 (14, 15).”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 3×
“In fact, two recent articles showed dramatic functional and structural impairments of mitochondria in Drosophila bearing null mutations for dPINK1 (14, 15).”
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Self-citationThe PINK1/Parkin pathway regulates mitochondrial morphology
Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., & Pallanck, L. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709336105 · Cited by 885 · cited 2×
“How can one explain such a protective role of PINK1 in mitochondria? One possibility, raised by studies in flies, is that PINK1 is involved in the regulation of mitochondrial fission and fusion (16, 17).”
Cited by
Items 601–700 of 722
Todorovic, M., & Mellick, G. D. (2016) · InTech eBooks · doi:10.5772/65450 · Cited by 1
Prediction and targeted prevention of Parkinson's and Alzheimer's diseases
Mandel, S. A., Halperin, I. J. Y., Korczyn, A. D., & Morelli, M. (2009) · Cited by 1
Modeling Disorders of Movement
LeDoux, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00002-0 · Cited by 1
Experimental models for evaluation of direct nose-to-brain drug delivery
Agnihotri, V. V., Gorle, A. P., Pardeshi, C. V., & Surana, S. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00021-7 · Cited by 2
Crosstalk Between Autophagy and Nutrigenomics in Neurodegenerative Diseases
Russell, A. E., Badr, A., Rai, A., Carafice, C., Rai, A., Daily, K. P., Whitham, O. D., Amer, A. O., Brown, C. M., & Dakhlallah, D. A. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-9205-5_13 · Cited by 1
Autophagy in Aging and Longevity
Nakamura, S., Shioda, T., & Yoshimori, T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_11 · Cited by 1
NOVEL CDNF/MANF PROTEIN FAMILY: MOLECULAR STRUCTURE, EXPRESSION AND NEUROTROPHIC ACTIVITY
Lindholm, P. (2009) · Helda - University of Helsinki Institutional Repository · Cited by 1
Tetrahydroisoquinoline Neurotoxins in Parkinson Disease
DeCuypere, M. G. (2010) · doi:10.21007/etd.cghs.2010.0067 · Cited by 2
Genetic Models of Parkinson’s Disease
Palubinsky, A. M., Lizama, B. N., Miller, D. L., & McLaughlin, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00014-5 · Cited by 1
The Significance of Mitophagy in Myocardial Ischaemia/ Reperfusion: the effect of melatonin
Dube, K. R. (2018) · SUNScholar (Stellenbosch University) · Cited by 2
Bureau, S. C. (2022) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2022-14889 · Cited by 1
Olanlokun, J. O., Babarinde, C. O., & Olorunsogo, O. O. (2023) · Research Square · doi:10.21203/rs.3.rs-3210506/v1 · Cited by 1
Hong, S., Shin, J., Saredy, J., Choi, S. Y., Wang, H., & Park, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.21.660867 · Cited by 1
Soto, I., McManus, R., Navarrete, W., Mhatre‐Winters, I., Rogers, E. V., Vancil, J., Doshier, K., Richardson, J. R., Nejtek, V. A., & Salvatore, M. F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.14.738586 · Cited by 1
Zebrafish as a Model for the Study of Parkinson’s Disease
Xi, Y. (2011) · uO Research (University of Ottawa) · doi:10.20381/ruor-4585
“abnormality although decreased dopamine release and impaired mitochondrial functions were noticed (Kitada et al., 2007; Gautier et al., 2008).”
BackgroundInfluentialInteraction Between Mitochondria and Autophagy
Gegg, M. E. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_3
Preclinical Models of Levodopa-Induced Dyskinesia
Francardo, V., & Cenci, M. A. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6503-3_18
Mitochondrial Involvement in Neurodegeneration and Aging
Pickrell, A. M. (2012)
Estudio de los mecanismos moleculares y celulares de la función protectora de la Apolipoproteína D
Bajo‐Grañeras, R. (2012) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/1714
Parkinson disease: identifying different players sharing a common principle
Farooqi, A. A., Arshad, S., Fayyaz, S., Abbas, S., & Bhatti, S. (2011) · Research in Biotechnology
Effect of Dietary Restriction on Muscle Performance in Drosophila
Hsu, P. (2011) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Hirano, S.-I., Ohashi, M., Kakihara, R., Suwabe, T., Fujimoto, T., Inoue, H., Uchihashi, K., & Nishikawa, Y. (2013) · Journal of Osaka Dental University · doi:10.18905/jodu.47.1_11
Mutations in Nuclear Genes That Affect Mitochondrial Function in Parkinson’s Disease
Charlesworth, G., & Wood, N. W. (2011) · Springer eBooks · doi:10.1007/978-0-85729-701-3_3
Neuronal Mitochondrial Transport
Knight, A. L., Chen, Y., Sun, T., & Sheng, Z. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch7
Mitochondria in Parkinson's Disease
Arena, G., & Valente, E. M. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch16
The role of RhoD in actin dynamics, receptor trafficking and cancer cell migration
Nehru, V. (2013) · Figshare
A Get‐Together to Tear It Apart
McLelland, G., & Fon, E. A. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch12
Neurobiology of Parkinson's Disease Gene Pink1 in Danio rerio (Zebrafish)
Priyadarshini, M. (2013) · Helda - University of Helsinki Institutional Repository
PINK1 as a Sensor for Mitochondrial Function
Steer, E. K., Dail, M. K., & Chu, C. T. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch11
The Neuroprotective Role of Micronutrients in Parkinson’s Disease
Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · doi:10.1201/9781420073522-7
Role of Mitochondria in Parkinson’s Disease and Huntington’s Disease
Schapira, A. H. V. (2012) · Oxidative stress and disease · doi:10.1201/b12308-23
Axonal transport and life cycle of mitochondria in Parkinson's disease model
Sung, H. W. (2016) · Purdue e-Pubs (Purdue University System)
Lassen, A. D. (2013) · ResearchWorks at the University of Washington (University of Washington)
Prasad, K. N. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_15
Misiak, M., & Arnold, S. (2010) · RWTH Publications (RWTH Aachen)
Defective Dynamics Of Mitochondria In Amyotrophic Lateral Sclerosis And Huntington's Disease
Song, W. (2012) · STARS (University of Central Florida)
ROS regulation of axonal mitochondrial transport
Liao, P. (2016) · Purdue e-Pubs (Purdue University System)
Butler, E. K. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3186
González-Hunt, C. P. (2017) · DukeSpace (Duke University)
GDNF and Neurturin isoforms in an experimental model of Parkinson's disease
Penttinen, A. (2017) · Helda - University of Helsinki Institutional Repository
The Development of an Inducible Akt as a Potential Gene Therapy for Parkinson’s Disease
Park, S. (2017) · Columbia Academic Commons (Columbia University) · doi:10.7916/d8sb4j50
Animal Models of Pathological Aging
Emmons, E. B., Kim, Y.-C., & Narayanan, N. S. (2018) · Wiley eBooks · doi:10.1002/9781118772034.ch4
Cell Therapy for Parkinson’s Disease
Chen, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00049-x · Cited by 3
Understanding the Role of Rhomboid Proteases and Their Substrates in Parkinson's Disease
Morrison, M. A. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3kd1qt41
Natural and Synthetic GHSR1a Agonists as Neuroprotective Agents in Models of Parkinson's disease
Rees, D. J. (2017) · Cronfa (Swansea University) · doi:10.23889/suthesis.40946
Relative Importance of Beta and Gamma Cytoplasmic Actins to Cellular and Organismal Viability
Patrinostro, X. (2018) · University of Minnesota Digital Conservancy (University of Minnesota)
Kane, M. S. (2016) · theses.fr (ABES) · doi:10.70675/13b2c4efz3c63z47d5za024z00dd62dd30b9
de Snoo, M. L. (2018) · TSpace (University of Toronto)
Silva, M., & Zheng, W. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_438
Kornmann, B. (2014) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.2111956.793490538
Hekimi, S. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717982023.793471865
(2013) · Elsevier eBooks · doi:10.1016/b978-0-12-388425-1.00023-3
Silva, M., & Zheng, W. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_438-1
The Neuroprotective Role of Micronutrients in Parkinson’s Disease
Tsika, E., Ischiropoulos, H., & Malkus, K. A. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch2
Westrate, L. M., & MacKeigan, J. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_206
Westrate, L. M., & MacKeigan, J. P. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_206
Animal Models and the Pathogenesis of Parkinson's Disease
Castaño, J. G., Iglesias, T., & de Yébenes, J. G. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00113
Assessment of mitochondrial function in neurotoxicology using alternative model organisms
(2023) · Advances in neurotoxicology · doi:10.1016/bs.ant.2023.01.001
Loss of PINK1 promotes the expansion of hematopoietic cells via upregulating autophagyPreprint
Yi, Z., Chen, X., & Chun‐Hang, A. (2023) · Research Square · doi:10.21203/rs.3.rs-2671385/v1
Mitochondria Are a Potential Therapeutic Target for Alzheimer’s Disease
Basavalingiah, A. J., Yan, S. F., & Yan, S. S. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190932183.013.23
Luo, Y., Xing, J., Wang, C., Yingqiu, W., Zhang, L., & Hongwei, L. (2024) · Research Square · doi:10.21203/rs.3.rs-3992734/v1
PINK1-G411S mutant increases kinase stability and enhances mitochondrial-linked functionsPreprint
Gonçalves, F. B., Enguita, F. J., & Morais, V. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.28.601304
“…in mitochondria and PD: Drosophila pink1 mutants show reduced life span, degeneration of flight muscles as well as dopaminergic neurons(17,18), while PINK1 KO mice have decreased dopamine levels and motor deficits(49) as well as impaired synaptic plasticity(50) and mitochondrial respiration(41,49).”
BackgroundInfluentialThe genetic basis of neurodegenerative disorders: Implications in Alzheimer's disease
Jilani, M. G., Hoque, M., Tabrez, S. S. M., & Ali, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00002-1 · Cited by 1
Wang, B., Wei, B., Lu, L., Liu, S., Ge, W., & Sun, M. (2025) · Neurogenetics · doi:10.1007/s10048-025-00827-6 · Cited by 1
Animal Models for the Study of Neurological Diseases and Their Link to Sleep
Rubio, C., González-Sánchez, E., Lee, Á., Ponce-Juárez, A., Serrano‐García, N., & Rubio‐Osornio, M. (2025) · Biomedicines · doi:10.3390/biomedicines13082005
“Genetic mutations in SNCA ( α -synuclein), PARK2 , PINK1 , DJ-1 , and LRRK2 affect protein aggregation and mitochondrial function, contributing to Lewy body formation and non-motor symptoms, including sleep disturbances [59–62].”
Lechner, S. A., & Kelm‐Nelson, C. A. (2025) · Medical Research Archives · doi:10.18103/mra.v13i10.6972
“…to PD 110 and, again, increased inflammation is hypothesized to play a key role in the onset of the disorder by specifically leading to increased ROS, oxidative stress, and abnormal mitochondrial functioning and these byproducts of cellular metabolism cause significant cellular damage 111,112 .”
Bertolin, G. (2013) · theses.fr (ABES) · doi:10.70675/85cf9b94z9680z40bfzaabezd31446437e10
“In parallel, as mutations on PINK1 were shown to affect mitochondrial complex I activity [137,138] and given that PINK1 does not bind directly to mTORC2, Wu et al.”
BackgroundThe role of Toll-like receptors in Parkinson's disease
Kennedy, C. (2023) · Apollo (University of Cambridge) · doi:10.17863/cam.106123
Ngo, D. M. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-22179 · Cited by 2
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062307
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062244
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062319
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062331
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062268
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062277
Agujetas, V. R., Barbero-Camps, E., de Dios, C., Podlesniy, P., Abadin, X., Morales, A., Marí, M., Trullás, R., & Colell, A. (2021) · Figshare · doi:10.6084/m9.figshare.14183579
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062229
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062253
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062343
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062337
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062292
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062223
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Figshare · doi:10.6084/m9.figshare.12062298
Westfall, S. (2018) · eScholarship@McGill (McGill) · doi:10.82308/37892
Ρύθμιση της έκφρασης της α-συνουκλεΐνης από πρωτεΐνες πρόσδεσης RNA
Kalloniati, K. (2020) · University of Thessaly Institutional Repository (University of Thessaly)
Wisner, S. R., Stein, C., Smith, E. E., Hoon, M., & Drerup, C. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.26.696432
“Pink1-mediated mitophagy is the most well studied mitophagy pathway which, when disrupted, leads to early onset Parkinson’s disease 9,10,45,46 .”
Characterization of Sex Differences in the AAV-A53T Alpha-Synuclein Rat Model of Parkinson's Disease
Ping, S. (2021) · TSpace (University of Toronto)
Uncovering the Selective Vulnerability of Dopaminergic Neurons
Davis, J. (2023) · Lehigh Preserve
ミトコンドリア品質管理におけるパーキンソン病の原因遺伝子産物PINK1と Parkinの解析
尾勝, 圭. (2014) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00007122
Metadata
- Authors
- Gautier, C. A., Kitada, T., & Shen, J.
- Affiliations
- Center for Neurologic Diseases, Brigham and Women's Hospital, Program in Neuroscience, Harvard Medical School, Boston, MA 02115
- Brigham and Women's Hospital (US)
- ORCID
- Shen, Jie
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-08-12
- Volume
- 105
- Issue
- 32
- Pages
- 11364-11369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2516271
- OpenAlex
- W1990287702
- Cited by
- 698
- References
- 39
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 24 · 2023: 29 · 2022: 37 · 2021: 32 · 2020: 48 · 2019: 30 · 2018: 36 · 2017: 33 · 2016: 49 · 2015: 37 · 2014: 46 · 2013: 45 · 2012: 53
- FWCI
- 34.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts Institute of Technology
- National Institute of Neurological Disorders and Stroke (R01NS041779, R01 NS41779)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, Parkinson's disease, mitochondrial dysfunction, mitochondrial respiration, oxidative stress, aconitase, striatum, cerebral cortex, nigrostriatal degeneration, dopaminergic neurons, aging, heat shock, hydrogen peroxide, TCA cycle
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Cerebral Cortex, Citric Acid Cycle, Corpus Striatum, Hydrogen Peroxide, Mitochondria, Oxygen Consumption, Parkinson Disease, Protein Kinases, Time Factors, Gene Deletion, Germ-Line Mutation, Mice, Knockout, Oxidative Stress, Heat-Shock Response, Mitochondrial Proteins, Mitochondrial Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.